it came out looks like a seesaw battle ending with high buying that ebbed at the EOD so its been that way all week actualy last 2 weeks again until some positive revenue news comes out this is a dead issue not gonna be much movement have you ever noticed when a pharmacuetical co. gets even to stage 2 trials the stock moves up and actually sometimes peaks before FDA approval because its already priced in thats because of ESTIMATED REVENUE until this CEO learns how to conduct business its doomed, hes either that stupid or hes a scam artist there is no other option
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.